Clinical Trials List
Protocol NumberH9P-MC-LNBF
2009-06-01 - 2010-05-31
Phase II/III
ICD-10F90.1
Attention-deficit hyperactivity disorder, predominantly hyperactive type
ICD-10F90.2
Attention-deficit hyperactivity disorder, combined type
ICD-10F90.8
Attention-deficit hyperactivity disorder, other type
ICD-10F90.9
Attention-deficit hyperactivity disorder, unspecified type
ICD-9314.01
Attention deficit disorder, with hyperactivity
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
27 participants
-
Global
270 participants
